1602 results
How to manage coronary artery disease in TAVI candidates?
20 May 2025 – From EuroPCR 2025
Martine Gilard, Antonio Mangieri, and Marco Barbanti explore the strategy for handling coronary artery disease in patients undergoing TAVI. Is coronary angiography always required beforehand? Should PCI be performed in all cases—and if so, when? This exchange offers key insights to help guide your decisions on...
FAITAVI - Major Late-Breaking Trial from EuroPCR 2025
22 May 2025 – From EuroPCR 2025
Presented at EuroPCR 2025, the FAITAVI trial brings new insights into the management of coronary artery disease in patients undergoing TAVI.
In this PCR Perspectives video, Stephan Windecker and Flavio Ribichini explore how the trial—the first of its kind—compared angiography-guided versus FFR-guided strategies for intermediate coronary lesions....
ViV challenges in degenerated sutureless bioprosthesis
08 Apr 2025
Watch this EuroIntervention image to learn how the collision of a TAV device during valve crossing in ViV TAVI can potentially cause instability or dehiscence of the sutureless bioprosthesis, contributing to severe poorly tolerated PVL.
Overcoming anatomical challenges in the lifetime management of young TAVI patients
27 Mar 2025
Watch this replay with D. Tchetche, S. Bleiziffer, D. Dvir and D. Talreja and learn about the criteria for valve selection before TAVI in young patients, and so much more!
Use of advanced coronary techniques in bailout of aortic valvuloplasty balloon entrapment
25 Mar 2025
Balloon entrapment in valvuloplasty can be life-threatening, especially after balloon rupture. Learn about a new technique involving balloon internalisation and safety snares for successful retrieval and sheath upsizing.
Impact of transcatheter or surgical aortic valve performance on 5-year outcomes in patients at ≥ intermediate risk
12 Mar 2025
The objective of this study was to validate standardised clinical criteria for BVD and evaluate its association with mortality and rehospitalisation, thereby guiding optimal valve selection in clinical practice.
Reviewer
Clinical impact of TAVI frame under-expansion and optimisation strategies
07 Mar 2025
Watch this replay with C. Cook, M. Grygier, A. Khokhar and W-K. Kim to learn about the clinical importance of TAVI frame under-expansion, and so much more!
International Women's Day 2025: Raising awareness of aortic stenosis in women: - a silent killer
08 Mar 2025
It was a day in October last year when I had a meeting with patients’ group in UK. At the time, I needed to discuss with them why a registry on valvular heart disease and sex disparities is needed. The camaraderie was incredible and the discussion...
Author
Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: primary biomarker analysis from the EARLY TAVR Trial
01 Apr 2025
Elad Asher provides his take on the primary biomarker analysis from the EARLY TAVR Trial presented by Brian R. Lindman at ACC.25 in Chicago.
Author
New insights from the early and delayed aortic valve replacement implant patients: a sub-analysis of the Early TAVR trial
29 Mar 2025
Luigi Biasco provides his take on a sub-analysis of the Early TAVR trial about the early and delayed aortic valve replacement implant patients presented by Philippe Genereux at ACC.25 in Chicago.
Author
5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)
01 Apr 2025
Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.
Author
Clinical and echocardiographic outcomes among the first 500 patients treated with a dedicated transcatheter aortic valve for pure aortic regurgitation in the Align-AR clinical trial
31 Mar 2025
Jonathan Curio interviews Raj Makkar about the results of the Align-AR trial which he presented during the ACC.25 in Chicago.
Author
Author
Routine cerebral embolic protection in transcatheter aortic valve implantation: the British Heart Foundation (BHF) PROTECT-TAVI trial
29 Mar 2025
Aaysha Cader and Ali Nazmi Calik provide their take on the BHF PROTECT-TAVI trial, presented by Rajesh Kharbanda at ACC.25 in Chicago.
Author
Author
Dapagliflozin in patients undergoing transcatheter aortic valve implantation (DapaTAVI)
10 Apr 2025
Chiara De Biase interviews Sergio Raposeiras-Roubin about the results of the DapaTAVI trial which he presented during the ACC.25 in Chicago.
Author
Author
Periprocedural management: TAVI
09 Feb 2025 – From PCR Tokyo Valves 2025
Want to elevate your expertise in TAVI periprocedural management? This session (in Japanese) is for you!
Discover the essential skills every team member needs for a smooth and successful TAVI procedure. Learn how radiologic technologists optimize imaging, how medical laboratory technologists provide critical real-time data, and how...
Hot topics in TAVI
09 Feb 2025 – From PCR Tokyo Valves 2025
Explore the latest hot topics in TAVI, including the impact of balloon-expandable TAVR valve deformation and calcium distribution on outcomes in bicuspid aortic valve, the outcomes of complex and high-risk vs. standard PCI in TAVI patients, hemodynamic outcomes after TAVI for aortic stenosis with small annuli,...
Combined valve disease
09 Feb 2025 – From PCR Tokyo Valves 2025
This session delves into the management of combined valve disease, covering topics such as transcatheter tricuspid valve replacement and valve-in-valve/valve-in-ring implantation in high-risk patients, the importance of CT imaging analysis in predicting true mitral stenosis in TAVI patients, the clinical outcomes of mild-to-moderate mixed aortic valve...
TAVI in challenging anatomy
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the challenges of TAVI in complex anatomies, including cases of extremely horizontal aorta, extra-large aortic annulus with calcified amorphous tumour-like mass, severe atherosclerotic aorta complicated by severe aortic stenosis, transfemoral TAVI for severe aortic regurgitation with Stanford type B aortic dissection, and optimal TAVI...
Sharper views, smarter moves: mini 4D TEE and 4D ICE in structural heart interventions
09 Feb 2025 – From PCR Tokyo Valves 2025
Don’t miss this PCR Tokyo Valves 2025 session replay, where experts dive into the clinical benefits of the Mini 4D TEE Probe in TAVR and LAAC procedures. Learn how this miniaturised probe enhances patient outcomes in TAVR, contributing to more efficient procedures and improved safety. Discover...
Lifetime management with self-expandable valve based on the latest evidence
09 Feb 2025 – From PCR Tokyo Valves 2025
Explore the latest evidence on the Evolut system and its impact on long-term valve durability in TAVR. Gain insights into its use for TAV-in-SAV procedures, the role of valve design in optimizing outcomes, and the importance of first-valve selection, commissure alignment, and coronary access.
